- THIS ARTICLE
-
Abstract
- Full Text (PDF)
- Alert me when this article is cited
- Alert me if a correction is posted
- SERVICES
- Similar articles in this journal
- Similar articles in PubMed
- Alert me to new issues of the journal
- Download to citation manager
- Reprints & Permissions
- CITING ARTICLES
- Citing Articles via HighWire
- Citing Articles via Google Scholar
- GOOGLE SCHOLAR
- Articles by Ueno, H.
- Articles by Yonesaki, T.
- Search for Related Content
- PUBMED
- PubMed Citation
- Articles by Ueno, H.
- Articles by Yonesaki, T.
Recognition and Specific Degradation of Bacteriophage T4 mRNAs
Hiroyuki Uenoa and Tetsuro Yonesakiaa Department of Biology, Graduate School of Science, Osaka University, Osaka 560-0043, Japan
Corresponding author: Tetsuro Yonesaki, Department of Biology, Graduate School of Science, Osaka University, 1-16 Machikaneyama-cho, Toyonaka-shi, Osaka 560-0043, Japan., yonesaki{at}bio.sci.osaka-u.ac.jp (E-mail)
Communicating editor: G. R. SMITH
| ABSTRACT |
|---|
Gene 61.5 of bacteriophage T4 has a unique role in gene expression. When this gene is mutated, mRNAs of many late genes are rapidly degraded, resulting in late-gene silencing. Here, we characterize an extragenic suppressor, ssf5, of a gene 61.5 mutation. ssf5 was found to be an amber mutation in motA, which encodes a transcription activator for T4 middle genes. When this gene is mutated, both degradation and specific cleavage of late-gene mRNA is induced after a delay, as exemplified by soc mRNA. Consequently, partial late-gene expression occurs. In an ssf5 genetic background, a gene 61.5 mutation exhibits a novel phenotype: in contrast to late-gene mRNA, middle-gene mRNA is stabilized and the expression of middle genes is prolonged. This is attributable to an activity of gene 61.5 specific for degradation of middle-gene mRNA. The degradation of middle-gene mRNA in the presence of a normal gene 61.5 appears in parallel with the degradation of late-gene mRNA in its absence. This observation suggests that the mRNA-degrading activity that silences late genes in cells infected with a gene 61.5 mutant is targeted to middle-gene mRNA when gene 61.5 is wild type. These results and the results obtained in the presence of a normal motA gene suggest that gene 61.5 protein functions to discriminate mRNAs for degradation in a stage-dependent manner.
BACTERIOPHAGE T4 has evolved a highly deterministic genetic program in which many scores of genes are expressed sequentially. T4 genes can be classified into three categories, early, middle, and late, according to when they are expressed. Gene 61.5 has an important role in T4 gene expression. When a 61.5 mutant infects Escherichia coli cells at low temperatures, mRNAs are destabilized and the expression of many late genes is blocked (![]()
![]()
Three different classes of promoters, early, middle, and late, initiate T4 transcription (![]()
-factor of RNA polymerase is replaced by a T4-specific
-factor, and the RNA polymerase ultimately recognizes late promoters to express late genes (![]()
![]()
![]()
![]()
![]()
In this article, we describe an extragenic suppressor, ssf5, of a gene 61.5 mutation. The ssf5 mutant turned out to carry an amber mutation in motA, which encodes a transcription activator for middle promoters (![]()
![]()
| MATERIALS AND METHODS |
|---|
Phage and bacterial strains:
The wild-type T4D and mutant phages amSF16 (gene 61.5-), nd28 (denA-), rII
PT8 (
rII-denB), and GT7 were laboratory stocks. GT7 was used for making T4 deoxycytosine-containing (dC) DNA (![]()
![]()
![]()
PT8 was constructed by recombination. We used the E. coli strains MH1 (hsdR- sup0), BB (sup0), and CR63 (supD).
Plasmids and marker-rescue test:
The 616-bp KpnI-PstI fragment, corresponding to T4 nucleotides 162884163500 (GenBank accession no. NC_000866), was obtained by digestion of T4 dC DNA. pBOT401 was constructed by an insertion of the 616-bp fragment between the KpnI and PstI sites of pBluescript II KS+ (Stratagene, La Jolla, CA). The cloned fragment had one EcoRI site in its middle. pBOT402 or 403 was derived from pBOT401 by digestion with EcoRI plus PstI or with EcoRI plus KpnI, respectively, blunting with T4 DNA polymerase and self-ligation. The marker-rescue test was performed according to ![]()
PT8 phage was propagated on MH1 cells harboring pBOT401, -402, or -403, and the progeny were examined for plaque size on BB cells. The efficiency of marker rescue calculated from the ratio of normal-size plaques to total plaques was 0.03 for pBOT401, 0.02 for pBOT403, and <0.001 for pBOT402.
Labeling and analysis of newly synthesized proteins:
MH1 cells were grown to a density of 5 x 108 cells/ml in M9 minimal medium supplemented with 0.3% casamino acids, 1 µg/ml thiamine, and 20 µg/ml tryptophan and infected at 30° at a multiplicity of infection of 10 with T4 phage. [35S]Methionine/cysteine (American Radiolabeled Chemicals, St. Louis, MO; >37 TBq/mmol) was added to a 0.1-ml culture at 3.7 MBq/ml at various times after infection to label newly synthesized proteins for 3 min. Under these conditions,
105 cpm was usually incorporated into the trichloroacetic acid-insoluble fraction in the wild-type-infected cell culture. Labeled proteins from an equal portion of infected cells were analyzed by electrophoresis through an 8%, unless otherwise stated, polyacrylamide gel containing 0.1% SDS. After an autoradiograph was taken with a Bio-Image analyzer (Fuji BAS-2000II), the intensity of signal was quantified by the National Institutes of Health (NIH) image program.
Northern blot analysis:
RNAs were extracted as described previously (![]()
-32P]ATP (Institute of Isotopes of the Hungarian Academy of Sciences, Hungary, 259 TBq/mmol) and another unlabeled primer; primers 1520 nucleotides long were used to amplify T4 nucleotides (GenBank accession no. NC_000866) 16794116881 for the rIIB gene; 1523415647 for the soc gene; 114773115153 for the uvsY gene; 106258106518 for gene 23; 107361107848 for gene 24; 3192332260 for gene 45; and 3443934924 for gene 46. Template DNA was previously prepared by PCR using the same primer set used for each probe synthesis with either plasmid or T4 DNA as a template and purified by polyacrylamide gel electrophoresis. The labeled probes were heat denatured immediately before use. After an autoradiograph had been taken with a Bio-Image analyzer, the signal intensity was quantified with the NIH image program.
Primer extension analysis:
The DNA primer, 5'-gttattaaccagttactttc, was complementary to the 3' terminal portion of soc mRNA. Primer extension was conducted with avian myeloblastosis virus reverse transcriptase as described previously (![]()
| RESULTS |
|---|
The phenotype and locus of the ssf5 mutation:
When a 61.5 mutant infects E. coli cells, the expression of many late genes is blocked, causing the growth defect of this mutant (![]()
![]()
|
The ssf5 mutant produced
30 progeny particles per infected cell (about one-third of the wild-type number) after a 10- to 20-min delay. These characteristics and the map position of ssf5 were reminiscent of the motA mutations. The calculated molecular mass of the motA protein is 23.6 kD (![]()
![]()
Next, the sequence from the wild-type motA gene was found to rescue the ssf5 mutation (see MATERIALS AND METHODS). In the corresponding region of ssf5 phage DNA, we detected one base substitution: G at nucleotide 313 of the motA coding region (![]()
The effect of motA mutation on late-gene expression in the gene 61.5 mutant:
Because it was isolated as a suppressor of the growth defect of a gene 61.5 mutant (![]()
In the wild-type-infected cells, different classes of proteins synthesized sequentially were discernible. Consistent with our previous work (![]()
The burst size (mean number of progeny particles per infected cell) of 61.5- motA- was
3, significantly higher than 0.1 with 61.5- phage but apparently lower than 30 with motA- phage. Thus, the suppression of the gene 61.5 mutation by a motA mutation was rather weak. This observation prompted us to characterize the late gene expression of 61.5- motA- in more detail to look for a difference from that of motA- (Fig 2A). Densitometric scanning of the radioactivity in each protein band (Fig 2B) revealed that the rates of synthesis of gp7, gp10, gp23, gp24, and gp37 were lower in cells infected with 61.5- motA- phage than in motA--infected cells. Remarkably, the difference in rates of synthesis between 61.5- motA- and motA- increased with time; rates in 61.5- motA- remained constant or declined slightly after 30 min, while increasing in motA-.
|
The fate of late-gene transcripts in the gene 61.5 mutant in a motA- genetic background:
Because the lower proficiency of late-protein synthesis by 61.5- motA- than by motA- might have resulted from a difference in mRNA abundance, we compared the quantities of some late-gene transcripts by Northern blotting. Three distinct species of full-length gene 23 transcripts can be produced by transcription initiated by late promoters located upstream of genes 21, 22, or 23 (![]()
![]()
![]()
![]()
|
A mutation in gene 61.5 does not affect transcription, and reduced late-gene expression results from extensive degradation of mRNA (![]()
|
Two possibilities may account for the still significant but reduced rate of mRNA degradation in the 61.5- mutant. One is that the activity degrading mRNA itself is partially impaired, and the other is that the activation of mRNA degradation is delayed, that is, that mRNA is not destabilized early at late stages of infection but is destabilized late. As shown in Fig 3A&NDASH;C, the abundance of late transcripts increased from 20 to 40 min in motA--infected cells. In 61.5- motA--infected cells, it increased from 20 to 30 min, but decreased by 40 min. This observation favored the second possibility above.
To explore this possibility more directly, we measured the decay rate of the full-length soc transcript at two different times. Its half-life in 61.5- motA--infected cells was 22 min when rifampicin was added at 23 min after infection. However, it was only 4.9 min when measured after adding rifampicin at 40 min. As a control, we also measured transcript half-lives of wild-type, 61.5-, and motA- phages at the same times in parallel experiments. In all cases, the half-life was nearly constant regardless of when it was measured: 30 min for wild type, 3.0 min for 61.5-, and 40 min for motA- (Fig 5 and data not shown). Thus, the half-life measured at the early time in 61.5- motA--infected cells was as long as that in wild-type- or motA--infected cells, while the half-life measured at the late time was as short as that in 61.5--infected cells. Therefore, during the late stages of 61.5- motA- infection, the soc transcript was initially stable but later became unstable. This result strongly suggests that the activation of soc mRNA degradation is delayed in 61.5- motA--infected cells.
|
Cleavage of soc transcripts:
To address whether the activity degrading mRNA in 61.5- motA--infected cells is the same as that in 61.5--infected cells, we investigated the degradation intermediates of soc transcripts using the primer-extension method to detect cleavages specific to the gene 61.5 mutant. In Fig 6, two prominent bands correspond to the 5' end of the full-length soc transcript and the 5' end of transcripts from which 59 nucleotides at the 5' terminus of the full-length soc transcript were deleted. This truncated species is generated by processing early transcripts initiated from early promoters 1 kb and 1.5 kb upstream of soc (![]()
|
The gene 61.5 mutant-specific cleavages were prominent at 20 min after infection with 61.5-. These cleavages were at or below the detectable level at 20 min after infection with wild-type phage and at 40 min after infection with motA-. These cleavages were also weak at 20 min after infection with 61.5- motA-. However, they were discernible with this double mutant at 30 min and became prominent at 40 min. Thus, cleavage in a gene 61.5 mutant-specific manner was detectable, but the induction of such activity occurred fairly late in 61.5- motA--infected cells.
The early termination of middle-gene expression by gene 61.5:
Comparing gene expression between 61.5- motA- and motA- (Fig 2) made us aware of an additional differencethat the expression of middle genes was prolonged in 61.5- motA--infected cells. For example, synthesis of gp39, gp43, and gp46 was discernible until 40 min after infection with 61.5- motA-, although it almost ceased by 30 min with motA- (Fig 2A). Densitometric measurements revealed that the rate of synthesis of these proteins declined abruptly after 20 min in motA--infected cells, while it remained at nearly the maximal level until 30 min in 61.5- motA--infected cells (Fig 2C). This observation reveals a novel phenotype of gene 61.5 in the control of middle-gene expression, namely, that it has a role in the early termination of middle-gene expression.
The effect of gene 61.5 on the stability of middle-gene transcripts:
To determine whether gene 61.5 affects middle-gene mRNA, we compared the transcripts of genes 45 (DNA clamp protein) and 46. Both exhibited prolonged expression when gene 61.5 was mutated (Fig 2A and data not shown). In accordance with previous results (![]()
![]()
We also investigated other typical middle-gene transcripts, such as from rIIB (membrane protein) and uvsY (enhancer of uvsX protein). The rIIB protein is one of the easiest to identify by one-dimensional polyacrylamide gel electrophoresis. In fact, independent experiments revealed that the synthesis of rIIB protein abruptly decreased to less than the detectable level at 30 min after infection with motA-, while only gradually decreasing and remaining still detectable until 40 min after infection with 61.5- motA- (refer to Fig 7). In spite of the ease of identifying rIIB protein, we detected not distinct but extensively smeared rIIB transcripts, presumably because of multiple transcription start sites and/or transcript processing. Therefore, we quantified the rIIB transcript by dot-blot hybridization. RNA hybridizable with an rIIB probe decreased rapidly at 30 min after infection with motA-, while gradually decreasing through 40 min after infection with 61.5- motA- (Fig 3F). The result for uvsY transcripts is shown in Fig 3G. Distinct species designated L or M correspond to transcripts initiated from a 0.8-kb upstream late promoter or from a just-upstream middle promoter, respectively (![]()
|
These results suggested that the prolonged expression of some middle genes in 61.5- motA--infected cells results from the persistence of mRNA. Transcription from middle promoters should cease after substitution of an RNA-polymerase
-factor at late stages of T4 infection (![]()
![]()
The effect of gene 61.5 on the functional decay of mRNA:
The functional decay rate is estimated from the ability of mRNA to direct the synthesis of protein after transcription has been blocked by rifampicin. Because this method can provide information simultaneously about the stability of various mRNAs, we used it to test the universality of the opposite effects of gene 61.5 on the stability of middle-gene and late-gene mRNAs. Rifampicin was added to the culture at 25 min after infection with motA- or 61.5- motA- and rates of synthesis of individual proteins were measured by pulse labeling with [35S]methionine/cysteine and analyzing by SDS-polyacrylamide gel electrophoresis (Fig 7). The decline in the rate of protein synthesis was apparently steeper for all the middle proteins, indicated on the right side of Fig 7, when gene 61.5 was normal than when it was inactivated. In contrast, the opposite tendency was observed for all the late proteins. Table 1 summarizes the functional half-lives of mRNA calculated from the results shown in Fig 7. The half-life of middle-gene mRNA in the presence of wild-type 61.5 was 1.2- to 4.0-fold shorter than in its absence, whereas that of late-gene mRNA was 1.5- to 2.6-fold longer in the presence than in the absence of wild-type 61.5.
|
We also measured the functional half-life of middle-gene mRNAs in the presence of wild-type motA gene. As shown in Fig 1, middle-gene expression of wild type and 61.5- phage was similar at 9 min after infection. It was increased in wild-type-infected cells at 18 min. By contrast, it was apparently reduced by 18 min in 61.5--infected cells. This reduction would be attributable to gene 61.5 mutant-specific middle-gene mRNA degradation between middle and late stages (see DISCUSSION) and usually occurs between 10 and 16 min. Thereafter, middle-gene expression was gradually decreased. To measure the functional half-life of middle-gene mRNA at late stages, rifampicin was added to the culture at 16 min after infection with wild type or 61.5-, and rates of synthesis of individual proteins were measured (Fig 8). Table 1 also summarizes the functional half-lives of mRNA calculated from the results shown in Fig 8. The half-life of middle-gene mRNA in the presence of wild-type 61.5 was 2.2-- to 3.0-fold shorter than in its absence.
|
| DISCUSSION |
|---|
The ssf5 mutation was isolated through its ability to suppress the growth defect of a gene 61.5 mutation (![]()
![]()
![]()
![]()
![]()
![]()
A mutation in gene 61.5 strongly destabilizes late-gene mRNA, and the resulting mRNA scarcity silences many late genes (![]()
![]()
An intriguing outcome from this study is the discovery of a novel phenotype of gene 61.5 in the motA- genetic background. As shown by measurements of chemical and functional decay rates, middle-gene mRNA was more slowly degraded at late stages of infection when gene 61.5 was mutated than when it was wild type (Fig 4 and Fig 7, Table 1). Consequently, the expression of middle genes was prolonged in cells infected with a gene 61.5 mutant (Fig 2). These effects of the gene 61.5 mutation on middle genes contrast with those on late genes (rapid degradation of late-gene mRNA and reduced expression of late genes). These phenotypes strongly suggest that gene 61.5 has opposing roles in mRNA metabolism at late stages of infection, roles of both destabilization of middle-gene mRNA and stabilization of late-gene mRNA. This unique property may be attributable solely to gene 61.5 mutation but not to a combination with motA mutation, because gene 61.5 mutation also stabilized middle-gene mRNAs at late stages of infection in the presence of the wild-type motA gene (Fig 8 and Table 1).
How does a single gene oppositely affect the stabilities of different classes of mRNA? When rates of protein synthesis were compared in the presence and absence of a normal gene 61.5 (Fig 2), there was no significant difference until 20 min after infection, when middle-gene expression was maximized. The destabilization of middle-gene mRNA by gene 61.5 became evident only thereafter. The difference in the abundance of middle-gene mRNA in the presence and absence of a normal gene 61.5 appeared from 20 to 30 min (Fig 3). The abundance of middle transcripts such as those of genes 45, 46, rIIB, and uvsY was similar at 10 and 20 min, regardless of whether gene 61.5 was normal or mutated. However, these transcripts abruptly disappeared at 30 min when gene 61.5 was normal, suggesting that the gene 61.5-specific degradation of middle-gene mRNA was activated between 20 and 30 min. These kinetics appear to parallel the kinetics of destabilization of late-gene mRNA by a gene 61.5 mutation. From these observations, we conclude that gene 61.5 has a role in targeting mRNAs for degradation. In this hypothesis, the mRNA degradation process is activated when infection proceeds into late stages, and when gene 61.5 is mutated, the process targets late-gene mRNAs. Gene 61.5 plays a role in targeting the process toward otherwise untargeted middle-gene mRNAs. As a consequence, late-gene mRNAs escape degradation. In other words, late-gene mRNA degradation specific to a gene 61.5 mutant was originally aimed at middle-gene mRNAs, when their function is completed, by the function of gp61.5.
Stabilization of late-gene mRNA and destabilization of middle-gene mRNA by gene 61.5 must require an intracellular process starting at early stages during which gp61.5 is synthesized (![]()
![]()
![]()
In T4-infected cells, mRNAs can be classified into four groups: host mRNA and T4 early-gene, middle-gene, and late-gene mRNAs. Each group, except late-gene mRNA, would be sequestered at suitable stages to help a quick shift of gene expression. At the early stage, host gene expression is rapidly shut off. This shut-off may be caused by degradation of host mRNA. At the middle stage, early-gene mRNA must be eliminated. T4 endoribonuclease regB can cleave both host mRNA and early-gene mRNA in the middle of the 5'-GGAG located in the ribosome binding site (![]()
![]()
| ACKNOWLEDGMENTS |
|---|
We cordially thank Dr. John W. Drake at the National Institute of Environmental Health Sciences for critical reading and invaluable help with the manuscript. We thank all the staff of the Radioisotope Research Center at Toyonaka, Osaka University, where all our experiments using radioisotope were carried out, for facilitation of our research.
Manuscript received November 2, 2000; Accepted for publication January 29, 2001.
| LITERATURE CITED |
|---|
ADELMAN, K., E. N. BRODY, and M. BUCKLE, 1998 Stimulation of bacteriophage T4 middle transcription by the T4 proteins, MotA and AsiA, occurs at two distinct steps in the transcription cycle. Proc. Natl. Acad. Sci. USA 95:15247-15252
CHRISTENSEN, A. C., and E. T. YOUNG, 1984 Characterization of T4 transcripts, pp. 184188 in Bacteriophage T4, edited by C. K. MATHEWS, E. KUTTER, G. MOSIG and P. B. BERGET. American Society for Microbiology, Washington, DC.
GRUIDL, M. E., T. C. CHEN, S. GARGANO, A. STORLAZZI, and A. CASCINO et al., 1991 Two bacteriophage T4 base plate genes (25 and 26) and the DNA repair gene uvsY belong to spatially and temporally overlapping transcription units. Virology 184:359-369[Medline].
HINTON, M. D., 1991 Transcription from a bacteriophage T4 middle promoter using T4 MotA protein and phage-modified RNA polymerase. J. Biol. Chem. 266:18034-18044
HSU, T. and J. D. KARAM, 1990 Transcriptional mapping of a DNA replication gene cluster in bacteriophage T4. J. Biol. Chem. 265:5305-5316.
KAI, T., H. E. SELICK, and T. YONESAKI, 1996 Destabilization of bacteriophage T4 mRNAs by a mutation of gene 61.5. Genetics 144:7-14[Abstract].
KAI, T., H. UENO, and T. YONESAKI, 1998 Involvement of other bacteriophage T4 genes in the blockade of protein synthesis and mRNA destabilization by a mutation of gene 61.5. Virology 248:148-155[Medline].
KAI, T., H. UENO, Y. OTSUKA, W. MORIMOTO, and T. YONESAKI, 1999 Gene 61.3 of bacteriophage T4 is the spackle gene. Virology 260:254-259[Medline].
KASSAVETIS, G. A. and E. P. GEIDUSCHEK, 1982 Defining a bacteriophage T4 late promoter: bacteriophage T4 gene 55 protein suffices for directing late promoter recognition. Proc. Natl. Acad. Sci. USA 81:5101-5105.
MACDONALD, P. M., E. KUTTER, and G. MOSIG, 1984 Regulation of a bacteriophage T4 late gene, soc, which maps in an early region. Genetics 106:17-27
MATHEWS, C. K., 1994 An overview of the T4 developmental program, pp. 18 in Molecular Biology of Bacteriophage T4, edited by J. D. KARAM, J. W. DRAKE, K. N. KREUZER, G. MOSIG, D. H. HALL, F. A. EISERLING, L. W. BLACK, E. K. SPICER, E. KUTTER, K. CARLSON and E. S. MILLER. American Society for Microbiology, Washington, DC.
MATTSON, T. G., V. HOUWE, and H. R. EPSTEIN, 1978 Isolation and characterization of conditional lethal mutations in the motA gene of bacteriophage T4. J. Mol. Biol. 126:551-570[Medline].
MOSIG, G., and D. H. HALL, 1994 Gene expression: A paradigm of integrated circuits, pp. 127131 in Molecular Biology of Bacteriophage T4, edited by J. D. KARAM, J. W. DRAKE, K. N. KREUZER, G. MOSIG, D. H. HALL, F. A. EISERLING, L. W. BLACK, E. K. SPICER, E. KUTTER, K. CARLSON and E. S. MILLER. American Society for Microbiology, Washington, DC.
O'FARRELL, Z. P. and M. L. GOLD, 1973 The identification of prereplicative bacteriophage T4 protein. J. Biol. Chem. 248:5499-5505
PULITZER, J. F., M. COLOMBO, and M. CIARAMELLA, 1985 New control elements of bacteriophage T4 pre-replicative transcription. J. Mol. Biol. 182:249-263[Medline].
SANSON, B., R. M. HU, E. TROITSKAYA, N. MATHY, and M. UZAN, 2000 Endoribonuclease RegB from bacteriophage T4 is necessary for the degradation of early but not middle or late mRNAs. J. Mol. Biol. 297:1063-1074[Medline].
STEVENS, A., 1972 New small polypeptides associated with DNA-dependent RNA polymerase of Escherichia coli after infection with bacteriophage T4. Proc. Natl. Acad. Sci. USA 69:603-607
UZAN, M., R. FAVRE, and E. BRODY, 1988 A nuclease that cuts specifically in the ribosome binding site of some T4 mRNAs. Proc. Natl. Acad. Sci. USA 85:8895-8899
UZAN, M., E. BRODY, and R. FAVRE, 1990 Nucleotide sequence and control of transcription of the bacteriophage T4 motA regulatory gene. Mol. Microbiol. 4:1487-1496[Medline].
WILSON, G. G., K. K. Y. YOUNG, and G. J. EDLIN, 1979 High-frequency generalized transduction by bacteriophage T4. Nature 280:80-82[Medline].
YOUNG, E. T., R. C. MENARD, and J. HARADA, 1981 Monocistronic and polycistronic bacteriophage T4 gene 23 message. J. Virol. 40:790-799
This article has been cited by other articles:
![]() |
H. Yamanishi and T. Yonesaki RNA Cleavage Linked With Ribosomal Action Genetics, October 1, 2005; 171(2): 419 - 425. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Otsuka and T. Yonesaki A Novel Endoribonuclease, RNase LS, in Escherichia coli Genetics, January 1, 2005; 169(1): 13 - 20. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Piesiniene, L. Truncaite, A. Zajanckauskaite, and R. Nivinskas The sequences and activities of RegB endoribonucleases of T4-related bacteriophages Nucleic Acids Res., October 14, 2004; 32(18): 5582 - 5595. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. Miller, E. Kutter, G. Mosig, F. Arisaka, T. Kunisawa, and W. Ruger Bacteriophage T4 Genome Microbiol. Mol. Biol. Rev., March 1, 2003; 67(1): 86 - 156. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Otsuka, H. Ueno, and T. Yonesaki Escherichia coli Endoribonucleases Involved in Cleavage of Bacteriophage T4 mRNAs J. Bacteriol., February 1, 2003; 185(3): 983 - 990. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kai and T. Yonesaki Multiple Mechanisms for Degradation of Bacteriophage T4 soc mRNA Genetics, January 1, 2002; 160(1): 5 - 12. [Abstract] [Full Text] [PDF] |
||||
- THIS ARTICLE
-
Abstract
- Full Text (PDF)
- Alert me when this article is cited
- Alert me if a correction is posted
- SERVICES
- Similar articles in this journal
- Similar articles in PubMed
- Alert me to new issues of the journal
- Download to citation manager
- Reprints & Permissions
- CITING ARTICLES
- Citing Articles via HighWire
- Citing Articles via Google Scholar
- GOOGLE SCHOLAR
- Articles by Ueno, H.
- Articles by Yonesaki, T.
- Search for Related Content
- PUBMED
- PubMed Citation
- Articles by Ueno, H.
- Articles by Yonesaki, T.











